Alpert JE, et al. “S-adenosyl-L-methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder: An Open Trial Following Partial or Nonresponse to Selective Serotonin Reuptake Inhibitors or Venlafaxine,” Journal of Clinical Psychopharmacology (Dec. 2004): Vol. 24, No. 6, pp. 661–64.
Coppen A, et al. “Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomised, Placebo Controlled Trial,” Journal of Affective Disorders (Nov. 2000): Vol. 60, No. 2, pp. 121–30.
Eisenberg DM, et al. “Trends in Alternative Medicine Use in the United States, 1990–1997: Results of a Follow-Up National Survey,” Journal of the American Medical Association (Nov. 11, 1998): Vol. 280, No. 18, pp. 1569–75.
Fava M, et al. “Rapidity of Onset of the Antidepressant Effect of Parenteral S-adenosyl-L-methionine,” Psychiatry Research (April 28, 1995): Vol. 56, No. 3, pp. 295–97.
Freeman MP, et al. “Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry,” Journal of Clinical Psychiatry (Dec. 2006): Vol. 67, No. 12, pp. 1954–67.
Hypericum Depression Trial Study Group. “Effect of Hypericum Perforatum (St. John’s wort) in Major Depressive Disorder: A Randomized Controlled Trial,” Journal of the American Medical Association (April 10, 2002): Vol. 287, No. 14, pp. 1807–14.
Kessler RC, et al. “The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States,” American Journal of Psychiatry (Feb. 2001): Vol. 158, No. 2, pp. 289–94.
Linde K, et al. “St John’s Wort for Depression,” Cochrane Database of Systematic Reviews (April 18, 2005): Document No. CD000448.
Marangell LB, et al. “A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression,” American Journal of Psychiatry (May 2003): Vol. 160, No. 5, pp. 996–98.
Mischoulon D. “Update and Critique of Natural Remedies as Antidepressant Treatments,” Psychiatric Clinics of North America (March 2007): Vol. 30, No. 1, pp. 51–68.
Natural Medicines Comprehensive Database. “Natural Medicines in the Clinical Management of Depression.” Accessed via Web: www.naturaldatabase.com, March 24, 2008.
Natural Standard Research Collaboration. “Folate (Folic Acid),” August 1, 2006. Accessed via Web: www.nlm.nih.gov/medlineplus.
Nemets B, et al. “Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder,” American Journal of Psychiatry (March 2002): Vol. 159, No. 3, pp. 477–79.
Peet M, et al. “A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients with Ongoing Depression Despite Apparently Adequate Treatment with Standard Drugs,” Archives of General Psychiatry (Oct. 2002): Vol. 59, No. 10, pp. 913–19.
Rey JM, et al. “Complementary and Alternative Medicine (CAM) Treatments and Pediatric Psychopharmacology,” Journal of the American Academy of Child and Adolescent Psychiatry (April 2008): Vol. 47, No. 4, pp. 364–68.
Shelton RC, et al. “Effectiveness of St. John’s wort in Major Depression: A Randomized Controlled Trial,” Journal of the American Medical Association (April 18, 2001): Vol. 285, No. 15, pp. 1978–86.
Su KP, et al. “Omega-3 Fatty Acids in Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Trial,” European Neuropsychopharmacology (Aug. 2003): Vol. 13, No. 4, pp. 267–71.
Tanskanen A, et al. “Fish Consumption, Depression, and Suicidality in a General Population,” Archives of General Psychiatry (May 2001): Vol. 58, No. 5, pp. 512–13.
Taylor MJ, et al. “Folate for Depressive Disorders,” Cochrane Database of Systematic Reviews (2003): Doc. No. CD003390.
Tiemeier H, et al. “Plasma Fatty Acid Composition and Depression are Associated in the Elderly: The Rotterdam Study,” American Journal of Clinical Nutrition (July 2003): Vol. 78, No. 1, pp. 40–46.